# FDA Inspection 846919 - CSL Plasma Inc. - August 15, 2013

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/7ec306f7-4a2b-4ff1-96db-b11de84e35ef
Source feed: FDA_Inspections

> FDA Inspection 846919 for CSL Plasma Inc. on August 15, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 846919
- Company Name: CSL Plasma Inc.
- Inspection Date: 2013-08-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1066921 - 2018-09-19](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/9abbe6df-c862-48e3-ab3d-fd1da12c3e82)
- [FDA Inspection 962510 - 2016-01-21](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/7cceab54-462a-47a3-ae0a-2179558a6040)

Company: https://www.keypedia.com/companies/csl-plasma-inc/d95f041f-b79a-4968-851d-b935db6c0d0b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d